iShares Biotechnology ETF

IBB

$209.25

Updated: 25/09/2026, 08:50:35

Market Cap

$10.34B

Sector

Financial Services

Industry

Asset Management

Country

Stock valuation chart

One-year closing share-price history for IBB

Company Profile

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.

USD

NASDAQ

https://www.ishares.com/us/products/239699/ishares-biotechnology-etf

Asset Summaries

Latest generated summaries for IBB

No summaries found.

Detailed business

Structured knowledge from the latest official annual filing.

No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.

Full company information

Latest profile, trading, valuation, and identifier data stored for IBB.

Share price: $209.25
Market cap: $10.34B
Exchange: NASDAQ
Currency: USD
CEO: N/A
Employees: N/A
IPO date: 12/02/2001
Beta: 0.713
Last dividend: $0.00
Day range: $205.60 – $209.52
52-week range: $139.20 – $217.12
1-day performance: 1.28%
1-year performance: 50.32%
Current drawdown (1Y): -3.62%
CIK: 0001100663
CUSIP: 464287556
ISIN: US4642875565
Created: 07/12/2025, 04:38:20
Last update: 25/09/2026, 08:50:35

Track iShares Biotechnology ETF with an AI analyst

See which prediction-market events move IBB, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Create a free account See what the world decides next

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News

News linked to IBB from your Railway `news_articles` table.

AV Laboratories, Founded by Pioneers of IVF Solutions, to Launch Fertility Clinic Program Featuring Its Award-Winning Skincare at ESHRE 2026 in London

Business Wire • STOCK • 21/05/2026, 11:27:00

Biotech Investors Are Tuning Out the MAHA Chaos

WSJ • STOCK • 20/05/2026, 07:30:00

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Zacks Investment Research • STOCK • 28/04/2026, 09:20:36

Should You Invest in the iShares Biotechnology ETF (IBB)?

Zacks Investment Research • STOCK • 21/04/2026, 09:20:24

Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead

24/7 Wall Street • STOCK • 28/03/2026, 16:50:54

DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing

The Motley Fool • STOCK • 21/03/2026, 18:38:01

Aster Capital Management DIFC Ltd Makes New Investment in iShares Biotechnology ETF $IBB

Defense World • STOCK • 27/02/2026, 04:30:55

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Zacks Investment Research • STOCK • 25/02/2026, 08:21:21

Should You Invest in the iShares Biotechnology ETF (IBB)?

Zacks Investment Research • STOCK • 17/02/2026, 08:20:25